A

Aptose Biosciences
D

APTO

0.18800
USD
-0.05
(-21.67%)
Market Closed
Volume
186,890
EPS
-2
Div Yield
-
P/E
-0
Market Cap
3,669,982
News

Title: Aptose Biosciences

Sector: Healthcare
Industry: Biotechnology
Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The Company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities.